113 related articles for article (PubMed ID: 20051756)
21. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.
Fabre S; Gibert C; Lechiche C; Jorgensen C; Sany J
J Rheumatol; 2005 Dec; 32(12):2432-3. PubMed ID: 16331777
[TBL] [Abstract][Full Text] [Related]
22. Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis?
Ang HT; Helfgott S
J Rheumatol; 2003 Nov; 30(11):2315-8. PubMed ID: 14677170
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis.
Franklin G; Greenspan J; Chen S
Ann Clin Lab Sci; 2009; 39(2):192-5. PubMed ID: 19429808
[TBL] [Abstract][Full Text] [Related]
24. [Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: a case description and literature review].
Moreno D; Martínez P; Berbegal J; Femenia M
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):261-2. PubMed ID: 19729230
[No Abstract] [Full Text] [Related]
25. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor.
Winthrop KL
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):602-10. PubMed ID: 17075599
[TBL] [Abstract][Full Text] [Related]
26. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
Danko JR; Gilliland WR; Miller RS; Decker CF
Scand J Infect Dis; 2009; 41(4):252-5. PubMed ID: 19266397
[TBL] [Abstract][Full Text] [Related]
27. Visceral leishmaniasis infection during adalimumab therapy: a case report and literature review.
Tung Chen Y; Perales C; Lacruz J; Senent L; Salavert M
Int J Rheum Dis; 2014 Sep; 17(7):822-4. PubMed ID: 24980576
[No Abstract] [Full Text] [Related]
28. Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept.
Bagalas V; Kioumis I; Argyropoulou P; Patakas D
Clin Rheumatol; 2007 Aug; 26(8):1344-5. PubMed ID: 16865310
[TBL] [Abstract][Full Text] [Related]
29. Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection?
Tektonidou MG; Skopouli FN
Clin Rheumatol; 2008 Apr; 27(4):541-2. PubMed ID: 17963018
[TBL] [Abstract][Full Text] [Related]
30. Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature.
Català A; Roé E; Dalmau J; Pomar V; Muñoz C; Yelamos O; Puig L
Dermatology; 2015; 230(3):204-7. PubMed ID: 25633623
[TBL] [Abstract][Full Text] [Related]
31. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.
Eriksson C; Engstrand S; Sundqvist KG; Rantapää-Dahlqvist S
Ann Rheum Dis; 2005 Mar; 64(3):403-7. PubMed ID: 15297281
[TBL] [Abstract][Full Text] [Related]
32. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors.
Exarchou SA; Voulgari PV; Markatseli TE; Zioga A; Drosos AA
Scand J Rheumatol; 2009; 38(5):328-31. PubMed ID: 19579151
[TBL] [Abstract][Full Text] [Related]
33. [Infliximab in aggressive and refractory rheumatoid arthritis. A pilot study].
Caramaschi P; Canestrini S; Biasi D; Carletto A; Scambi C; Scarperi A; Bambara LM
Recenti Prog Med; 2002 Jan; 93(1):19-24. PubMed ID: 11850995
[TBL] [Abstract][Full Text] [Related]
34. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
Geraghty EM; Ristow B; Gordon SM; Aronowitz P
Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458
[TBL] [Abstract][Full Text] [Related]
35. [Leishmaniasis in rheumatoid arthritis].
Pizzorni C; Secchi ME; Cutolo M
Reumatismo; 2007; 59(3):235-9. PubMed ID: 17898884
[TBL] [Abstract][Full Text] [Related]
36. Septic arthritis due to Roseomonas mucosa in a rheumatoid arthritis patient receiving infliximab therapy.
Sipsas NV; Papaparaskevas J; Stefanou I; Kalatzis K; Vlachoyiannopoulos P; Avlamis A
Diagn Microbiol Infect Dis; 2006 Aug; 55(4):343-5. PubMed ID: 16626905
[TBL] [Abstract][Full Text] [Related]
37. Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate.
Nakashima C; Tanioka M; Takahashi K; Miyachi Y
Clin Exp Dermatol; 2008 Jul; 33(4):437-9. PubMed ID: 18485021
[TBL] [Abstract][Full Text] [Related]
38. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
39. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
[TBL] [Abstract][Full Text] [Related]
40. [Case of miliary tuberculosis during treatment with infliximab for rheumatoid arthritis].
Taniguchi H; Izumi S
Kekkaku; 2008 May; 83(5):431-4. PubMed ID: 18536334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
